Jiangsu Akcome Science and Technology Co., Ltd. Logo

Jiangsu Akcome Science and Technology Co., Ltd.

002610.SZ

(0.2)
Stock Price

0,37 CNY

-10.46% ROA

-44.5% ROE

-1.55x PER

Market Cap.

1.657.426.176,00 CNY

199.72% DER

0% Yield

-26.45% NPM

Jiangsu Akcome Science and Technology Co., Ltd. Stock Analysis

Jiangsu Akcome Science and Technology Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Jiangsu Akcome Science and Technology Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (82) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

2 ROE

Negative ROE (-20.9%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-5.54%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.55x) suggests it's overvalued, potentially making it an expensive investment.

5 DER

The company has a high debt to equity ratio (132%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

Jiangsu Akcome Science and Technology Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Jiangsu Akcome Science and Technology Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Jiangsu Akcome Science and Technology Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Jiangsu Akcome Science and Technology Co., Ltd. Revenue
Year Revenue Growth
2008 377.803.567
2009 553.872.638 31.79%
2010 1.247.954.726 55.62%
2011 1.524.113.975 18.12%
2012 1.362.435.009 -11.87%
2013 1.931.028.073 29.45%
2014 3.002.783.511 35.69%
2015 3.215.583.814 6.62%
2016 3.904.992.406 17.65%
2017 4.856.493.249 19.59%
2018 4.842.707.329 -0.28%
2019 5.126.010.313 5.53%
2020 3.016.317.076 -69.94%
2021 2.531.045.711 -19.17%
2022 6.690.548.250 62.17%
2023 3.581.993.278 -86.78%
2023 4.661.979.060 23.17%
2024 2.536.876.160 -83.77%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Jiangsu Akcome Science and Technology Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 42.653.313 100%
2013 25.499.587 -67.27%
2014 16.842.483 -51.4%
2015 20.962.178 19.65%
2016 36.492.264 42.56%
2017 31.323.983 -16.5%
2018 41.918.613 25.27%
2019 40.773.967 -2.81%
2020 37.662.300 -8.26%
2021 39.046.786 3.55%
2022 73.215.471 46.67%
2023 84.617.101 13.47%
2023 78.771.499 -7.42%
2024 55.954.244 -40.78%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Jiangsu Akcome Science and Technology Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 4.807.401
2009 10.514.015 54.28%
2010 21.033.521 50.01%
2011 33.913.014 37.98%
2012 41.519.274 18.32%
2013 28.380.410 -46.3%
2014 29.716.719 4.5%
2015 31.036.975 4.25%
2016 83.569.151 62.86%
2017 85.174.741 1.89%
2018 115.477.492 26.24%
2019 129.068.047 10.53%
2020 77.306.294 -66.96%
2021 105.889.979 26.99%
2022 105.086.439 -0.76%
2023 463.991.674 77.35%
2023 85.589.909 -442.11%
2024 248.475.632 65.55%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Jiangsu Akcome Science and Technology Co., Ltd. EBITDA
Year EBITDA Growth
2008 56.643.951
2009 66.694.984 15.07%
2010 140.558.097 52.55%
2011 288.775.426 51.33%
2012 52.706.387 -447.89%
2013 189.388.590 72.17%
2014 505.906.853 62.56%
2015 753.198.575 32.83%
2016 1.081.768.723 30.37%
2017 1.111.773.938 2.7%
2018 1.201.989.136 7.51%
2019 34.274.786 -3406.92%
2020 690.091.344 95.03%
2021 56.219.558 -1127.49%
2022 -276.703.856 120.32%
2023 73.519.236 476.37%
2023 -268.312.450 127.4%
2024 -680.305.230 60.56%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Jiangsu Akcome Science and Technology Co., Ltd. Gross Profit
Year Gross Profit Growth
2008 79.075.300
2009 99.591.368 20.6%
2010 213.737.135 53.4%
2011 229.157.556 6.73%
2012 103.935.332 -120.48%
2013 258.684.001 59.82%
2014 483.990.195 46.55%
2015 603.584.604 19.81%
2016 710.603.838 15.06%
2017 847.588.994 16.16%
2018 871.284.818 2.72%
2019 742.273.781 -17.38%
2020 448.746.866 -65.41%
2021 61.599.707 -628.49%
2022 -62.873.062 197.97%
2023 263.494.493 123.86%
2023 274.337.761 3.95%
2024 -213.710.772 228.37%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Jiangsu Akcome Science and Technology Co., Ltd. Net Profit
Year Net Profit Growth
2008 47.995.858
2009 48.721.320 1.49%
2010 101.467.327 51.98%
2011 197.263.945 48.56%
2012 -56.039.724 452.01%
2013 8.452.947 762.96%
2014 92.016.774 90.81%
2015 111.254.565 17.29%
2016 147.433.897 24.54%
2017 113.455.312 -29.95%
2018 125.342.472 9.48%
2019 -1.668.831.903 107.51%
2020 29.525.695 5752.13%
2021 -419.875.440 107.03%
2022 -827.000.016 49.23%
2023 -103.731.492 -697.25%
2023 -826.435.159 87.45%
2024 -851.999.526 3%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Jiangsu Akcome Science and Technology Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Jiangsu Akcome Science and Technology Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2008 -54.045.265
2009 -42.381.739 -27.52%
2010 -147.246.649 71.22%
2011 -808.409.761 81.79%
2012 -564.065.127 -43.32%
2013 -620.672.670 9.12%
2014 -897.461.925 30.84%
2015 -1.170.490.778 23.33%
2016 -2.532.666.745 53.78%
2017 -188.289.705 -1245.09%
2018 -44.420.004 -323.88%
2019 112.780.478 139.39%
2020 199.610.411 43.5%
2021 164.641.341 -21.24%
2022 -89.924.275 283.09%
2023 -741.197.979 87.87%
2023 -337.496.890 -119.62%
2024 -89.316.089 -277.87%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Jiangsu Akcome Science and Technology Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2008 -14.849.792
2009 13.726.018 208.19%
2010 57.396.705 76.09%
2011 -253.463.728 122.64%
2012 147.162.056 272.23%
2013 -176.918.411 183.18%
2014 -80.056.876 -120.99%
2015 386.119.357 120.73%
2016 39.021.298 -889.51%
2017 871.339.865 95.52%
2018 868.538.493 -0.32%
2019 825.310.241 -5.24%
2020 584.290.786 -41.25%
2021 536.077.429 -8.99%
2022 183.878.915 -191.54%
2023 -452.374.616 140.65%
2023 -236.802.209 -91.03%
2024 -21.067.294 -1024.03%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Jiangsu Akcome Science and Technology Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2008 39.195.473
2009 56.107.757 30.14%
2010 204.643.354 72.58%
2011 554.946.033 63.12%
2012 711.227.183 21.97%
2013 443.754.259 -60.28%
2014 817.405.050 45.71%
2015 1.556.610.135 47.49%
2016 2.571.688.043 39.47%
2017 1.059.629.570 -142.7%
2018 912.958.497 -16.07%
2019 712.529.762 -28.13%
2020 384.680.375 -85.23%
2021 371.436.088 -3.57%
2022 273.803.190 -35.66%
2023 288.823.363 5.2%
2023 100.694.681 -186.83%
2024 68.248.795 -47.54%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Jiangsu Akcome Science and Technology Co., Ltd. Equity
Year Equity Growth
2008 101.502.743
2009 176.860.216 42.61%
2010 431.971.788 59.06%
2011 1.401.126.240 69.17%
2012 1.271.182.193 -10.22%
2013 1.311.835.735 3.1%
2014 2.383.289.232 44.96%
2015 2.498.520.207 4.61%
2016 5.776.246.005 56.74%
2017 5.787.606.243 0.2%
2018 5.942.641.689 2.61%
2019 4.110.615.531 -44.57%
2020 4.097.326.926 -0.32%
2021 3.759.501.679 -8.99%
2022 3.207.070.109 -17.23%
2023 3.208.869.069 0.06%
2023 2.312.914.851 -38.74%
2024 2.081.060.235 -11.14%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Jiangsu Akcome Science and Technology Co., Ltd. Assets
Year Assets Growth
2008 281.419.730
2009 448.219.106 37.21%
2010 866.220.207 48.26%
2011 2.711.010.978 68.05%
2012 3.514.396.838 22.86%
2013 4.355.245.407 19.31%
2014 8.423.742.626 48.3%
2015 12.180.309.236 30.84%
2016 16.508.384.118 26.22%
2017 17.082.786.381 3.36%
2018 14.056.677.310 -21.53%
2019 11.645.285.537 -20.71%
2020 9.592.832.932 -21.4%
2021 9.095.480.554 -5.47%
2022 11.561.010.459 21.33%
2023 11.503.193.453 -0.5%
2023 10.423.125.927 -10.36%
2024 10.453.010.380 0.29%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Jiangsu Akcome Science and Technology Co., Ltd. Liabilities
Year Liabilities Growth
2008 179.916.987
2009 271.358.889 33.7%
2010 434.248.417 37.51%
2011 1.309.884.736 66.85%
2012 2.243.214.644 41.61%
2013 3.043.409.671 26.29%
2014 6.040.453.393 49.62%
2015 9.681.789.028 37.61%
2016 10.732.138.112 9.79%
2017 11.295.180.137 4.98%
2018 8.114.035.621 -39.21%
2019 7.534.670.005 -7.69%
2020 5.495.506.005 -37.11%
2021 5.335.978.873 -2.99%
2022 8.353.940.349 36.13%
2023 8.294.324.384 -0.72%
2023 8.110.211.075 -2.27%
2024 8.371.950.144 3.13%

Jiangsu Akcome Science and Technology Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.9
Net Income per Share
-0.24
Price to Earning Ratio
-1.55x
Price To Sales Ratio
0.41x
POCF Ratio
-5.92
PFCF Ratio
-2.7
Price to Book Ratio
0.91
EV to Sales
0.92
EV Over EBITDA
-5.17
EV to Operating CashFlow
-13.27
EV to FreeCashFlow
-6.06
Earnings Yield
-0.65
FreeCashFlow Yield
-0.37
Market Cap
1,66 Bil.
Enterprise Value
3,72 Bil.
Graham Number
1.48
Graham NetNet
-0.24

Income Statement Metrics

Net Income per Share
-0.24
Income Quality
0.26
ROE
-0.44
Return On Assets
-0.1
Return On Capital Employed
-0.45
Net Income per EBT
0.85
EBT Per Ebit
0.99
Ebit per Revenue
-0.31
Effective Tax Rate
0.08

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.01
Operating Profit Margin
-0.31
Pretax Profit Margin
-0.31
Net Profit Margin
-0.26

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.28
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.06
Free CashFlow per Share
-0.14
Capex to Operating CashFlow
-1.19
Capex to Revenue
0.08
Capex to Depreciation
2.26
Return on Invested Capital
-0.21
Return on Tangible Assets
-0.1
Days Sales Outstanding
271.44
Days Payables Outstanding
269.53
Days of Inventory on Hand
41.32
Receivables Turnover
1.34
Payables Turnover
1.35
Inventory Turnover
8.83
Capex per Share
0.07

Balance Sheet

Cash per Share
1,07
Book Value per Share
0,46
Tangible Book Value per Share
0.42
Shareholders Equity per Share
0.41
Interest Debt per Share
0.83
Debt to Equity
2
Debt to Assets
0.35
Net Debt to EBITDA
-2.87
Current Ratio
0.67
Tangible Asset Value
1,88 Bil.
Net Current Asset Value
-3,23 Bil.
Invested Capital
625270711
Working Capital
-2,50 Bil.
Intangibles to Total Assets
0.02
Average Receivables
2,42 Bil.
Average Payables
2,90 Bil.
Average Inventory
437230385.5
Debt to Market Cap
2.19

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Jiangsu Akcome Science and Technology Co., Ltd. Dividends
Year Dividends Growth
2012 1
2016 0 0%

Jiangsu Akcome Science and Technology Co., Ltd. Profile

About Jiangsu Akcome Science and Technology Co., Ltd.

Jiangsu Akcome Science and Technology Co., Ltd. manufactures photovoltaic solar accessories in the People's Republic of China. It also operates photovoltaic power stations. Jiangsu Akcome Science and Technology Co., Ltd. was founded in 2006 and is headquartered in Zhangjiagang, the People's Republic of China.

CEO
Mr. Chenghui Zou
Employee
1.812
Address
No. 101, Jintang West Road
Zhangjiagang, 215600

Jiangsu Akcome Science and Technology Co., Ltd. Executives & BODs

Jiangsu Akcome Science and Technology Co., Ltd. Executives & BODs
# Name Age
1 Mr. Chenghui Zou
Chairman, President & Acting Secretary of the Board of Directors
70
2 Mr. Jinjian Zhang
Vice President & Director
70
3 Mr. Zhouxiang Shi
Vice President, Chief Financial Officer & Non-Independent Director
70

Jiangsu Akcome Science and Technology Co., Ltd. Competitors